Defining and Refining the Role for Surgery and Intraperitoneal Chemotherapy in the Treatment of Peritoneal Surface Malignancies

Ann Surg Oncol. 2020 Jan;27(1):73-75. doi: 10.1245/s10434-019-07956-x. Epub 2019 Oct 23.

Authors

M Haroon Choudry¹, David L Bartlett¹, H Richard Alexander², Kiran K Turaga³

Affiliations

¹ Surgical Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
² Department of Surgery, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
³ Department of Surgery, University of Chicago, Chicago, IL, USA. kturaga@uchicago.edu.

PMID: 31646448
DOI: 10.1245/s10434-019-07956-x

No abstract available

Publication types

Editorial

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Combined Modality Therapy
Cytoreduction Surgical Procedures / methods*
Humans
Hyperthermia, Induced / methods*
Peritoneal Neoplasms / pathology
Peritoneal Neoplasms / therapy*
Prognosis
Survival Rate